Predict your next investment

TherOptix company logo
HEALTHCARE | Drug Delivery

See what CB Insights has to offer

Founded Year

2018

Stage

Debt | Alive

Total Raised

$3.5M

Last Raised

$3.5M | 2 yrs ago

About TherOptix

TherOptix is an early-stage biopharmaceutical company focused on optimizing therapeutic benefit and clinical outcomes by delivering controlled, modifiable drug concentrations through a contact lens to the front and/or back of the eye. The innovative, non-invasive technology platform enables clinically impactful therapeutic delivery.

TherOptix Headquarter Location

689 Main Street #305

Walpole, Massachusetts, 02081,

United States

Latest TherOptix News

TherOptix - Monty Montoya Appointed CEO

Jul 21, 2021

July 20, 2021 – Boston – Monty Montoya has been named chief executive officer of TherOptix, a pre-clinical biopharma company focused on delivering clinically impactful therapeutics via a drug-eluding contact lens platform. TherOptix has received orphan drug designation on its lead candidate (001) for prevention of proliferative vitreoretinopathy (PVR). “TherOptix is developing a novel ophthalmic drug delivery platform that has the potential to be a patient game-changer. I look forward to leading this great team through regulatory approval and commercialization,” said Monty Montoya, “TherOptix will offer patients the safest and most efficacious way for critical medicines to be delivered to the front and back of the eye.”  Shared by Tyler Stowater, board member of TherOptix, Inc.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.